Industry Research Reports

Home > Reports > Chemical & Material > Global Nicotinamide Riboside (NR) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Global Nicotinamide Riboside (NR) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Industry: Chemical & Material

Published Date: 2024-04-16

Pages: 143 Pages

Report ld: 2693795

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Nicotinamide Riboside (NR) Market Size(US$)

CAGR 2024-2030

8.3%

Market Size,2030

USD 39

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 24 million

Market Forecast in 2030(Value)

US$ 39 million

CAGR

8.3%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.

In fact, the market’s mainstream is selling NRC powder, the full name called nicotinamide riboside chloride. NRC is a chloride form of NR. 100 mg of nicotinamide riboside chloride provides about 88 mg of nicotinamide riboside. The report focuses on the Nicotinamide Riboside(NR) market, which has been converted.

The global Nicotinamide Riboside (NR) market was valued at US$ 21.46 million in 2022 and will reach US$ 38.76 million by the end of 2029, growing at a CAGR of 8.32% during 2023-2029.

The data for 2023 is an estimate, based on the historical data and the integrated view of industrial experts, manufacturers, distributors, and end users, etc.

Top-down and bottom-up approaches are used to validate the global Nicotinamide Riboside (NR) market size and to estimate the market size for company, regional division, product type and application (end users). In the complete market engineering process, both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

The global Nicotinamide Riboside (NR) market is projected to reach US$ 39 million by 2030 from an estimated US$ 24 million in 2024, at a CAGR of 8.3% during 2024 and 2030.

Global key players of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, etc. The top three players hold a share over 60%.

Asia-Pacific is the largest market, has a share about 39%, followed by North America, and Europe, with share 35% and 16%, separately.

In terms of product type, purity below 98% is the largest segment, occupied for a share of 63%, and in terms of application, health supplement has a share about 92 percent.

MARKET SEGMENTATION

By Company

ChromaDex
Genex Formulas
Shandong Tianming Pharmaceutical
Bontac
Longer Livetech
Tiantai Biotechnology
EnzymeWorks
Suzhou MyLand Pharm & Nutrition
Shenzhen Ejion Biotechnology
Zhejiang Jiahua
Weitai Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity ≤98%
Purity ＞98%

Segment by Application

Health Supplement
Pharmaceutical Additives

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Riboside (NR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Nicotinamide Riboside (NR).

The Nicotinamide Riboside (NR) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Riboside (NR) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nicotinamide Riboside (NR) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Nicotinamide Riboside (NR) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nicotinamide Riboside (NR) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Nicotinamide Riboside (NR) Product Introduction

1.2 Market by Type

1.2.1 Global Nicotinamide Riboside (NR) Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Purity ≤98%

1.2.3 Purity ＞98%

1.3 Market by Application

1.3.1 Global Nicotinamide Riboside (NR) Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Health Supplement

1.3.3 Pharmaceutical Additives

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Nicotinamide Riboside (NR) Market Size Estimates and Forecasts

2.1.1 Global Nicotinamide Riboside (NR) Revenue 2019-2030

2.1.2 Global Nicotinamide Riboside (NR) Sales 2019-2030

2.2 Nicotinamide Riboside (NR) Market Size by Region: 2023 Versus 2030

2.3 Nicotinamide Riboside (NR) Sales by Region (2019-2030)

2.3.1 Global Nicotinamide Riboside (NR) Sales by Region: 2019-2024

2.3.2 Global Nicotinamide Riboside (NR) Sales Forecast by Region (2025-2030)

2.3.3 Global Nicotinamide Riboside (NR) Sales Market Share by Region (2019-2030)

2.4 Nicotinamide Riboside (NR) Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Nicotinamide Riboside (NR) Revenue by Region: 2019-2024

2.4.2 Global Nicotinamide Riboside (NR) Revenue Forecast by Region (2025-2030)

2.4.3 Global Nicotinamide Riboside (NR) Revenue Market Share by Region (2019-2030)

3 Global Nicotinamide Riboside (NR) by Manufacturers

3.1 Global Top Nicotinamide Riboside (NR) Manufacturers by Sales

3.1.1 Global Nicotinamide Riboside (NR) Sales by Manufacturer (2019-2024)

3.1.2 Global Nicotinamide Riboside (NR) Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Nicotinamide Riboside (NR) Manufacturers by Revenue

3.2.1 Global Nicotinamide Riboside (NR) Revenue by Manufacturer (2019-2024)

3.2.2 Global Nicotinamide Riboside (NR) Revenue Share by Manufacturer (2019-2024)

3.3 Global Nicotinamide Riboside (NR) Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Nicotinamide Riboside (NR) Manufacturers Covered: Ranking by Revenue

3.4.2 Global Nicotinamide Riboside (NR) Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Nicotinamide Riboside (NR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Nicotinamide Riboside (NR) Manufacturing Base Distribution, Product Type

3.5.1 Nicotinamide Riboside (NR) Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Nicotinamide Riboside (NR) Product Type

3.5.3 Date of International Manufacturers Enter into Nicotinamide Riboside (NR) Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 ChromaDex

4.1.1 ChromaDex Company Information

4.1.2 ChromaDex Description, Business Overview

4.1.3 ChromaDex Nicotinamide Riboside (NR) Products Offered

4.1.4 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.1.5 ChromaDex Nicotinamide Riboside (NR) Sales by Product in 2023

4.1.6 ChromaDex Nicotinamide Riboside (NR) Sales by Application in 2023

4.1.7 ChromaDex Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.1.8 ChromaDex Recent Developments

4.2 Genex Formulas

4.2.1 Genex Formulas Company Information

4.2.2 Genex Formulas Description, Business Overview

4.2.3 Genex Formulas Nicotinamide Riboside (NR) Products Offered

4.2.4 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.2.5 Genex Formulas Nicotinamide Riboside (NR) Sales by Product in 2023

4.2.6 Genex Formulas Nicotinamide Riboside (NR) Sales by Application in 2023

4.2.7 Genex Formulas Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.2.8 Genex Formulas Recent Developments

4.3 Shandong Tianming Pharmaceutical

4.3.1 Shandong Tianming Pharmaceutical Company Information

4.3.2 Shandong Tianming Pharmaceutical Description, Business Overview

4.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Products Offered

4.3.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.3.5 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales by Product in 2023

4.3.6 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales by Application in 2023

4.3.7 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.3.8 Shandong Tianming Pharmaceutical Recent Developments

4.4 Bontac

4.4.1 Bontac Company Information

4.4.2 Bontac Description, Business Overview

4.4.3 Bontac Nicotinamide Riboside (NR) Products Offered

4.4.4 Bontac Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Bontac Nicotinamide Riboside (NR) Sales by Product in 2023

4.4.6 Bontac Nicotinamide Riboside (NR) Sales by Application in 2023

4.4.7 Bontac Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.4.8 Bontac Recent Developments

4.5 Longer Livetech

4.5.1 Longer Livetech Company Information

4.5.2 Longer Livetech Description, Business Overview

4.5.3 Longer Livetech Nicotinamide Riboside (NR) Products Offered

4.5.4 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Longer Livetech Nicotinamide Riboside (NR) Sales by Product in 2023

4.5.6 Longer Livetech Nicotinamide Riboside (NR) Sales by Application in 2023

4.5.7 Longer Livetech Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.5.8 Longer Livetech Recent Developments

4.6 Tiantai Biotechnology

4.6.1 Tiantai Biotechnology Company Information

4.6.2 Tiantai Biotechnology Description, Business Overview

4.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Products Offered

4.6.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales by Product in 2023

4.6.6 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales by Application in 2023

4.6.7 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.6.8 Tiantai Biotechnology Recent Development

4.7 EnzymeWorks

4.7.1 EnzymeWorks Company Information

4.7.2 EnzymeWorks Description, Business Overview

4.7.3 EnzymeWorks Nicotinamide Riboside (NR) Products Offered

4.7.4 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.7.5 EnzymeWorks Nicotinamide Riboside (NR) Sales by Product in 2023

4.7.6 EnzymeWorks Nicotinamide Riboside (NR) Sales by Application in 2023

4.7.7 EnzymeWorks Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.7.8 EnzymeWorks Recent Development

4.8 Suzhou MyLand Pharm & Nutrition

4.8.1 Suzhou MyLand Pharm & Nutrition Company Information

4.8.2 Suzhou MyLand Pharm & Nutrition Description, Business Overview

4.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Products Offered

4.8.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.8.5 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales by Product in 2023

4.8.6 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales by Application in 2023

4.8.7 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.8.8 Suzhou MyLand Pharm & Nutrition Recent Development

4.9 Shenzhen Ejion Biotechnology

4.9.1 Shenzhen Ejion Biotechnology Company Information

4.9.2 Shenzhen Ejion Biotechnology Description, Business Overview

4.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Products Offered

4.9.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.9.5 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales by Product in 2023

4.9.6 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales by Application in 2023

4.9.7 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.9.8 Shenzhen Ejion Biotechnology Recent Development

4.10 Zhejiang Jiahua

4.10.1 Zhejiang Jiahua Company Information

4.10.2 Zhejiang Jiahua Description, Business Overview

4.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Products Offered

4.10.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.10.5 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales by Product in 2023

4.10.6 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales by Application in 2023

4.10.7 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.10.8 Zhejiang Jiahua Recent Development

4.11 Weitai Pharmaceutical

4.11.1 Weitai Pharmaceutical Company Information

4.11.2 Weitai Pharmaceutical Description, Business Overview

4.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Products Offered

4.11.4 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)

4.11.5 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales by Product in 2023

4.11.6 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales by Application in 2023

4.11.7 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales by Geographic Area in 2023

4.11.8 Weitai Pharmaceutical Recent Development

5 Breakdown Data by Type

5.1 Global Nicotinamide Riboside (NR) Sales by Type (2019-2030)

5.1.1 Global Nicotinamide Riboside (NR) Sales by Type (2019-2024)

5.1.2 Global Nicotinamide Riboside (NR) Sales Forecast by Type (2025-2030)

5.1.3 Global Nicotinamide Riboside (NR) Sales Market Share by Type (2019-2030)

5.2 Global Nicotinamide Riboside (NR) Revenue Forecast by Type (2019-2030)

5.2.1 Global Nicotinamide Riboside (NR) Revenue by Type (2019-2024)

5.2.2 Global Nicotinamide Riboside (NR) Revenue Forecast by Type (2025-2030)

5.2.3 Global Nicotinamide Riboside (NR) Revenue Market Share by Type (2019-2030)

5.3 Nicotinamide Riboside (NR) Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Nicotinamide Riboside (NR) Sales by Application (2019-2030)

6.1.1 Global Nicotinamide Riboside (NR) Sales by Application (2019-2024)

6.1.2 Global Nicotinamide Riboside (NR) Sales Forecast by Application (2025-2030)

6.1.3 Global Nicotinamide Riboside (NR) Sales Market Share by Application (2019-2030)

6.2 Global Nicotinamide Riboside (NR) Revenue Forecast by Application (2019-2030)

6.2.1 Global Nicotinamide Riboside (NR) Revenue by Application (2019-2024)

6.2.2 Global Nicotinamide Riboside (NR) Revenue Forecast by Application (2025-2030)

6.2.3 Global Nicotinamide Riboside (NR) Revenue Market Share by Application (2019-2030)

6.3 Nicotinamide Riboside (NR) Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Nicotinamide Riboside (NR) Market Size YoY Growth 2019-2030

7.2 North America Nicotinamide Riboside (NR) Market Facts & Figures by Country

7.2.1 North America Nicotinamide Riboside (NR) Sales by Country (2019-2030)

7.2.2 North America Nicotinamide Riboside (NR) Revenue by Country (2019-2030)

7.3 North America Nicotinamide Riboside (NR) Sales by Type (2019-2024)

7.4 North America Nicotinamide Riboside (NR) Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Nicotinamide Riboside (NR) Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Nicotinamide Riboside (NR) Market Facts & Figures by Region

8.2.1 Asia-Pacific Nicotinamide Riboside (NR) Sales by Region (2019-2030)

8.2.2 Asia-Pacific Nicotinamide Riboside (NR) Revenue by Region (2019-2030)

8.3 Asia-Pacific Nicotinamide Riboside (NR) Sales by Type (2019-2024)

8.4 Asia-Pacific Nicotinamide Riboside (NR) Sales by Application (2019-2024)

9 Europe

9.1 Europe Nicotinamide Riboside (NR) Market Size YoY Growth 2019-2030

9.2 Europe Nicotinamide Riboside (NR) Market Facts & Figures by Country

9.2.1 Europe Nicotinamide Riboside (NR) Sales by Country (2019-2030)

9.2.2 Europe Nicotinamide Riboside (NR) Revenue by Country (2019-2030)

9.3 Europe Nicotinamide Riboside (NR) Sales by Type (2019-2024)

9.4 Europe Nicotinamide Riboside (NR) Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Nicotinamide Riboside (NR) Market Size YoY Growth 2019-2030

10.2 Latin America Nicotinamide Riboside (NR) Market Facts & Figures by Country

10.2.1 Latin America Nicotinamide Riboside (NR) Sales by Country (2019-2030)

10.2.2 Latin America Nicotinamide Riboside (NR) Revenue by Country (2019-2030)

10.3 Latin America Nicotinamide Riboside (NR) Sales by Type (2019-2024)

10.4 Latin America Nicotinamide Riboside (NR) Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Nicotinamide Riboside (NR) Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Nicotinamide Riboside (NR) Market Facts & Figures by Country

11.2.1 Middle East and Africa Nicotinamide Riboside (NR) Sales by Country (2019-2030)

11.2.2 Middle East and Africa Nicotinamide Riboside (NR) Revenue by Country (2019-2030)

11.3 Middle East and Africa Nicotinamide Riboside (NR) Sales by Type (2019-2024)

11.4 Middle East and Africa Nicotinamide Riboside (NR) Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Nicotinamide Riboside (NR) Supply Chain Analysis

12.2 Nicotinamide Riboside (NR) Key Raw Materials and Upstream Suppliers

12.3 Nicotinamide Riboside (NR) Clients Analysis

12.4 Nicotinamide Riboside (NR) Sales Channel and Sales Model Analysis

12.4.1 Nicotinamide Riboside (NR) Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Nicotinamide Riboside (NR) Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Nicotinamide Riboside (NR) Distributors

13 Market Dynamics

13.1 Nicotinamide Riboside (NR) Industry Trends

13.2 Nicotinamide Riboside (NR) Market Drivers

13.3 Nicotinamide Riboside (NR) Market Challenges

13.4 Nicotinamide Riboside (NR) Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Nicotinamide Riboside (NR) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Purity ≤98%

Table 3. Major Manufacturers of Purity ＞98%

Table 4. Global Nicotinamide Riboside (NR) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Nicotinamide Riboside (NR) Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Nicotinamide Riboside (NR) Sales by Region (2019-2024) & (MT)

Table 7. Global Nicotinamide Riboside (NR) Sales Forecast by Region (2025-2030) & (MT)

Table 8. Global Nicotinamide Riboside (NR) Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Nicotinamide Riboside (NR) Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 10. Global Nicotinamide Riboside (NR) Sales by Manufacturer (2019-2024) & (MT)

Table 11. Global Nicotinamide Riboside (NR) Sales Share by Manufacturer (2019-2024)

Table 12. Nicotinamide Riboside (NR) Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 13. Nicotinamide Riboside (NR) Revenue Share by Manufacturer (2019-2024)

Table 14. Key Manufacturers Nicotinamide Riboside (NR) Price (2019-2024) & (US$/MT)

Table 15. Ranking of Global Top Nicotinamide Riboside (NR) Manufacturers by Revenue (US$ Million) in 2023

Table 16. Global Nicotinamide Riboside (NR) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 17. Global Nicotinamide Riboside (NR) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nicotinamide Riboside (NR) as of 2023)

Table 18. Nicotinamide Riboside (NR) Manufacturers Manufacturing Base Distribution and Headquarters

Table 19. Manufacturers Nicotinamide Riboside (NR) Product Type

Table 20. Date of International Manufacturers Enter into Nicotinamide Riboside (NR) Market

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. ChromaDex Company Information

Table 23. ChromaDex Description and Business Overview

Table 24. ChromaDex Nicotinamide Riboside (NR) Product

Table 25. ChromaDex Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 26. ChromaDex Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 27. ChromaDex Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 28. ChromaDex Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 29. ChromaDex Recent Development

Table 30. Genex Formulas Company Information

Table 31. Genex Formulas Description and Business Overview

Table 32. Genex Formulas Nicotinamide Riboside (NR) Product

Table 33. Genex Formulas Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 34. Genex Formulas Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 35. Genex Formulas Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 36. Genex Formulas Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 37. Genex Formulas Recent Development

Table 38. Shandong Tianming Pharmaceutical Company Information

Table 39. Shandong Tianming Pharmaceutical Description and Business Overview

Table 40. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product

Table 41. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 42. Shandong Tianming Pharmaceutical Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 43. Shandong Tianming Pharmaceutical Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 44. Shandong Tianming Pharmaceutical Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 45. Shandong Tianming Pharmaceutical Recent Development

Table 46. Bontac Company Information

Table 47. Bontac Description and Business Overview

Table 48. Bontac Nicotinamide Riboside (NR) Product

Table 49. Bontac Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 50. Bontac Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 51. Bontac Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 52. Bontac Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 53. Bontac Recent Development

Table 54. Longer Livetech Company Information

Table 55. Longer Livetech Description and Business Overview

Table 56. Longer Livetech Nicotinamide Riboside (NR) Product

Table 57. Longer Livetech Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 58. Longer Livetech Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 59. Longer Livetech Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 60. Longer Livetech Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 61. Longer Livetech Recent Development

Table 62. Tiantai Biotechnology Company Information

Table 63. Tiantai Biotechnology Description and Business Overview

Table 64. Tiantai Biotechnology Nicotinamide Riboside (NR) Product

Table 65. Tiantai Biotechnology Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 66. Tiantai Biotechnology Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 67. Tiantai Biotechnology Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 68. Tiantai Biotechnology Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 69. Tiantai Biotechnology Recent Development

Table 70. EnzymeWorks Company Information

Table 71. EnzymeWorks Description and Business Overview

Table 72. EnzymeWorks Nicotinamide Riboside (NR) Product

Table 73. EnzymeWorks Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 74. EnzymeWorks Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 75. EnzymeWorks Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 76. EnzymeWorks Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 77. EnzymeWorks Recent Development

Table 78. Suzhou MyLand Pharm & Nutrition Company Information

Table 79. Suzhou MyLand Pharm & Nutrition Description and Business Overview

Table 80. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product

Table 81. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 82. Suzhou MyLand Pharm & Nutrition Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 83. Suzhou MyLand Pharm & Nutrition Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 84. Suzhou MyLand Pharm & Nutrition Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 85. Suzhou MyLand Pharm & Nutrition Recent Development

Table 86. Shenzhen Ejion Biotechnology Company Information

Table 87. Shenzhen Ejion Biotechnology Description and Business Overview

Table 88. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product

Table 89. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 90. Shenzhen Ejion Biotechnology Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 91. Shenzhen Ejion Biotechnology Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 92. Shenzhen Ejion Biotechnology Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 93. Shenzhen Ejion Biotechnology Recent Development

Table 94. Zhejiang Jiahua Company Information

Table 95. Zhejiang Jiahua Description and Business Overview

Table 96. Zhejiang Jiahua Nicotinamide Riboside (NR) Product

Table 97. Zhejiang Jiahua Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 98. Zhejiang Jiahua Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 99. Zhejiang Jiahua Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 100. Zhejiang Jiahua Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 101. Zhejiang Jiahua Recent Development

Table 102. Weitai Pharmaceutical Company Information

Table 103. Weitai Pharmaceutical Description and Business Overview

Table 104. Weitai Pharmaceutical Nicotinamide Riboside (NR) Product

Table 105. Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)

Table 106. Weitai Pharmaceutical Sales Proportion of Nicotinamide Riboside (NR) by Product in 2023

Table 107. Weitai Pharmaceutical Sales Proportion of Nicotinamide Riboside (NR) by Application in 2023

Table 108. Weitai Pharmaceutical Sales Proportion of Nicotinamide Riboside (NR) by Geographic Area in 2023

Table 109. Weitai Pharmaceutical Recent Development

Table 110. Global Nicotinamide Riboside (NR) Sales by Type (2019-2024) & (MT)

Table 111. Global Nicotinamide Riboside (NR) Sales Forecast by Type (2025-2030) & (MT)

Table 112. Global Nicotinamide Riboside (NR) Revenue by Type (2019-2024) & (US$ Million)

Table 113. Global Nicotinamide Riboside (NR) Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 114. Global Nicotinamide Riboside (NR) Sales by Application (2019-2024) & (MT)

Table 115. Global Nicotinamide Riboside (NR) Sales Forecast by Application (2025-2030) & (MT)

Table 116. Global Nicotinamide Riboside (NR) Revenue by Application (2019-2024) & (US$ Million)

Table 117. Global Nicotinamide Riboside (NR) Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 118. North America Nicotinamide Riboside (NR) Sales by Country (2019-2024) & (MT)

Table 119. North America Nicotinamide Riboside (NR) Sales by Country (2025-2030) & (MT)

Table 120. North America Nicotinamide Riboside (NR) Revenue by Country (2019-2024) & (US$ Million)

Table 121. North America Nicotinamide Riboside (NR) Revenue by Country (2025-2030) & (US$ Million)

Table 122. North America Nicotinamide Riboside (NR) Sales by Type (2019-2024) & (MT)

Table 123. North America Nicotinamide Riboside (NR) Sales by Application (2019-2024) & (MT)

Table 124. Asia-Pacific Nicotinamide Riboside (NR) Sales by Region (2019-2024) & (MT)

Table 125. Asia-Pacific Nicotinamide Riboside (NR) Sales by Region (2025-2030) & (MT)

Table 126. Asia-Pacific Nicotinamide Riboside (NR) Revenue by Region (2019-2030) & (US$ Million)

Table 127. Asia-Pacific Nicotinamide Riboside (NR) Revenue by Region (2025-2030) & (US$ Million)

Table 128. Asia-Pacific Nicotinamide Riboside (NR) Sales by Type (2019-2024) & (MT)

Table 129. Asia-Pacific Nicotinamide Riboside (NR) Sales by Application (2019-2024) & (MT)

Table 130. Europe Nicotinamide Riboside (NR) Sales by Country (2019-2024) & (MT)

Table 131. Europe Nicotinamide Riboside (NR) Sales by Country (2025-2030) & (MT)

Table 132. Europe Nicotinamide Riboside (NR) Revenue by Country (2019-2024) & (US$ Million)

Table 133. Europe Nicotinamide Riboside (NR) Revenue by Country (2025-2030) & (US$ Million)

Table 134. Europe Nicotinamide Riboside (NR) Sales by Type (2019-2024) & (MT)

Table 135. Europe Nicotinamide Riboside (NR) Sales by Application (2019-2024) & (MT)

Table 136. Latin America Nicotinamide Riboside (NR) Sales by Country (2019-2024) & (MT)

Table 137. Latin America Nicotinamide Riboside (NR) Sales by Country (2025-2030) & (MT)

Table 138. Latin America Nicotinamide Riboside (NR) Revenue by Country (2019-2024) & (US$ Million)

Table 139. Latin America Nicotinamide Riboside (NR) Revenue by Country (2025-2030) & (US$ Million)

Table 140. Latin America Nicotinamide Riboside (NR) Sales by Type (2019-2024) & (MT)

Table 141. Latin America Nicotinamide Riboside (NR) Sales by Application (2019-2024) & (MT)

Table 142. Middle East and Africa Nicotinamide Riboside (NR) Sales by Country (2019-2024) & (MT)

Table 143. Middle East and Africa Nicotinamide Riboside (NR) Sales by Country (2025-2030) & (MT)

Table 144. Middle East and Africa Nicotinamide Riboside (NR) Revenue by Country (2019-2024) & (US$ Million)

Table 145. Middle East and Africa Nicotinamide Riboside (NR) Revenue by Country (2025-2030) & (US$ Million)

Table 146. Middle East and Africa Nicotinamide Riboside (NR) Sales by Type (2019-2024) & (MT)

Table 147. Middle East and Africa Nicotinamide Riboside (NR) Sales by Application (2019-2024) & (MT)

Table 148. Nicotinamide Riboside (NR) Key Raw Materials, Industry Status and Trend

Table 149. Nicotinamide Riboside (NR) Key Raw Materials and Upstream Suppliers

Table 150. Nicotinamide Riboside (NR) Clients Status and Trend

Table 151. Nicotinamide Riboside (NR) Typical Clients

Table 152. Nicotinamide Riboside (NR) Distributors

Table 153. Nicotinamide Riboside (NR) Market Trends

Table 154. Nicotinamide Riboside (NR) Market Drivers

Table 155. Nicotinamide Riboside (NR) Market Challenges

Table 156. Nicotinamide Riboside (NR) Market Restraints

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Nicotinamide Riboside (NR) Product Picture

Figure 2. Global Nicotinamide Riboside (NR) Sales Market Share by Type in 2023 & 2030

Figure 3. Purity ≤98% Product Picture

Figure 4. Purity ＞98% Product Picture

Figure 5. Global Nicotinamide Riboside (NR) Sales Market Share by Application in 2023 & 2030

Figure 6. Health Supplement Examples

Figure 7. Pharmaceutical Additives Examples

Figure 8. Nicotinamide Riboside (NR) Report Years Considered

Figure 9. Global Nicotinamide Riboside (NR) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 10. Global Nicotinamide Riboside (NR) Market Size 2019-2030 (US$ Million)

Figure 11. Global Nicotinamide Riboside (NR) Sales 2019-2030 (MT)

Figure 12. Global Nicotinamide Riboside (NR) Sales Market Share Forecast by Region (2019-2030)

Figure 13. Global Nicotinamide Riboside (NR) Revenue Market Share by Region (2019-2030)

Figure 14. Global Nicotinamide Riboside (NR) Sales Share by Manufacturer in 2023

Figure 15. Nicotinamide Riboside (NR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 16. Global Nicotinamide Riboside (NR) Sales Market Share Forecast by Type (2019-2030)

Figure 17. Global Nicotinamide Riboside (NR) Revenue Market Share Forecast by Type (2019-2030)

Figure 18. Nicotinamide Riboside (NR) Average Selling Price (ASP) by Type (2019-2024) & (US$/MT)

Figure 19. Global Nicotinamide Riboside (NR) Sales Market Share Forecast by Application (2019-2030)

Figure 20. Global Nicotinamide Riboside (NR) Revenue Market Share Forecast by Application (2019-2030)

Figure 21. Nicotinamide Riboside (NR) Average Selling Price (ASP) by Application (2019-2024) & (US$/MT)

Figure 22. North America Nicotinamide Riboside (NR) Revenue 2019-2030 (US$ Million)

Figure 23. North America Nicotinamide Riboside (NR) Sales Market Share by Type (2019-2024)

Figure 24. North America Nicotinamide Riboside (NR) Sales Market Share by Application (2019-2024)

Figure 25. Asia-Pacific Nicotinamide Riboside (NR) Revenue 2019-2030 (US$ Million)

Figure 26. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share by Region (2019-2030)

Figure 27. Asia-Pacific Nicotinamide Riboside (NR) Revenue Market Share by Region (2019-2030)

Figure 28. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share by Type (2019-2024)

Figure 29. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share by Application (2019-2024)

Figure 30. Europe Nicotinamide Riboside (NR) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 31. Europe Nicotinamide Riboside (NR) Sales Market Share by Country (2019-2030)

Figure 32. Europe Nicotinamide Riboside (NR) Revenue Market Share by Country (2019-2030)

Figure 33. Europe Nicotinamide Riboside (NR) Sales Market Share by Type (2019-2024)

Figure 34. Europe Nicotinamide Riboside (NR) Sales Market Share by Application (2019-2024)

Figure 35. Latin America Nicotinamide Riboside (NR) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 36. Latin America Nicotinamide Riboside (NR) Sales Market Share by Country (2019-2030)

Figure 37. Latin America Nicotinamide Riboside (NR) Revenue Market Share by Country (2019-2024)

Figure 38. Latin America Nicotinamide Riboside (NR) Sales Market Share by Type (2019-2024)

Figure 39. Latin America Nicotinamide Riboside (NR) Sales Market Share by Application (2019-2024)

Figure 40. Middle East and Africa Nicotinamide Riboside (NR) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 41. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share by Country (2019-2030)

Figure 42. Middle East and Africa Nicotinamide Riboside (NR) Revenue Market Share by Country (2019-2030)

Figure 43. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share by Type (2019-2024)

Figure 44. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share by Application (2019-2024)

Figure 45. Nicotinamide Riboside (NR) Supply Chain (Upstream and Downstream Market)

Figure 46. Global Production Market Share of Nicotinamide Riboside (NR) Raw Materials by Region in 2023

Figure 47. Nicotinamide Riboside (NR) Distribution Channels

Figure 48. Global Nicotinamide Riboside (NR) Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 49. Global Nicotinamide Riboside (NR) Percentage 2019-2030: Online Sales VS Offline Sales

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Nicotinamide Riboside (NR) in 2030? zhanKai

The global market size of Nicotinamide Riboside (NR) in 2030 was 39 Million USD.

What is the annual compound growth rate of the global Nicotinamide Riboside (NR) market size from 2024 to 2030? shouQi

What was the global market size of Nicotinamide Riboside (NR) in 2024? shouQi

Which companies rank high in the global Nicotinamide Riboside (NR) market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Riboside (NR) market size was US$ 27.73 million in 2025 and is forecast to reach a readjusted size of US$ 48.14 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 94
USD 4250.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2026
The global Nicotinamide Riboside (NR) market was valued at US$ 27.73 million in 2025 and is anticipated to reach US$ 48.14 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 138
USD 2900.00
(Single User License)
Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 27.73 million in 2025 and is projected to reach US$ 48.14 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 3950.00
(Single User License)
Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Riboside (NR) market size was US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Riboside (NR) market is projected to grow from US$ 25.8 million in 2024 to US$ 44.8 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 162
USD 4900.00
(Single User License)
Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 112
USD 3950.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2025
The global market for Nicotinamide Riboside (NR) was valued at US$ 25.8 million in the year 2024 and is projected to reach a revised size of US$ 44.8 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published Date: 2025-01-19
Pages: 103
USD 2900.00
(Single User License)
Global Nicotinamide Riboside (NR) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-17
Pages: 174
USD 5600.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Insights, Forecast to 2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
Nicotinamide Riboside (NR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-01-18
Pages: 121
USD 3950.00
(Single User License)

Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Riboside (NR) market size was US$ 27.73 million in 2025 and is forecast to reach a readjusted size of US$ 48.14 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 94
USD 4250.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2026
The global Nicotinamide Riboside (NR) market was valued at US$ 27.73 million in 2025 and is anticipated to reach US$ 48.14 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 138
USD 2900.00 (Single User License)
Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 27.73 million in 2025 and is projected to reach US$ 48.14 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
USD 3950.00 (Single User License)
Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Riboside (NR) market size was US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Riboside (NR) market is projected to grow from US$ 25.8 million in 2024 to US$ 44.8 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 162
USD 4900.00 (Single User License)
Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 112
USD 3950.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2025
The global market for Nicotinamide Riboside (NR) was valued at US$ 25.8 million in the year 2024 and is projected to reach a revised size of US$ 44.8 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published: 2025-01-19
Pages: 103
USD 2900.00 (Single User License)
Global Nicotinamide Riboside (NR) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-17
Pages: 174
USD 5600.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Insights, Forecast to 2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-07
Pages: 106
USD 4900.00 (Single User License)
Nicotinamide Riboside (NR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-01-18
Pages: 121
USD 3950.00 (Single User License)